Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors
about
Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapyViral resistance to the thiazolo-iso-indolinones, a new class of nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptaseHuman immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutantsSusceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitorsAnalysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptaseA mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitorsSpecific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitorsU-90152, a potent inhibitor of human immunodeficiency virus type 1 replicationA nonnucleoside reverse transcriptase inhibitor active on human immunodeficiency virus type 1 isolates resistant to related inhibitorsComprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitorsActivity of a novel quinoxaline derivative against human immunodeficiency virus type 1 reverse transcriptase and viral replicationInhibition of human immunodeficiency virus integrase by bis-catecholsThe same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidineAnti-human immunodeficiency virus (HIV) activities of halogenated gomisin J derivatives, new nonnucleoside inhibitors of HIV type 1 reverse transcriptaseL-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase(Alkylamino) piperidine bis(heteroaryl)piperizine analogs are potent, broad-spectrum nonnucleoside reverse transcriptase inhibitors of drug-resistant isolates of human immunodeficiency virus type 1 (HIV-1) and select for drug-resistant variants of HPotent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-PolSubunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase.Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcriptionSensitivity of wild-type human immunodeficiency virus type 1 reverse transcriptase to dideoxynucleotides depends on template length; the sensitivity of drug-resistant mutants does not.Antiviral therapy for human immunodeficiency virus infectionsMolecular modeling studies of HIV-1 reverse transcriptase nonnucleoside inhibitors: total energy of complexation as a predictor of drug placement and activity.A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs.
P2860
Q27729365-A023A0C1-C4D3-42A9-B037-FC21EAAE3266Q28367526-2C11511E-1456-47BF-B0DA-DC2C9B8D1633Q28367531-F5F48D00-4166-4531-B078-D75BCD1E1C16Q28367570-B52311F4-45A7-492E-B96C-1F78BEABEFA2Q28367590-EB344C0E-8ABE-4D46-B56A-4D3E747DACEBQ28368003-A48C016C-31B3-466C-AE3D-7554E35B8960Q28368028-EEE5835C-989F-4C97-969E-380739FC56D1Q28368032-0CB46FFC-E0CC-424A-A343-F21BBE11A724Q28368034-4AAA12CD-437F-4FDE-8946-22AED96A610AQ28368038-C0AE64C8-5A7B-4828-9564-A7664E98E1DCQ28368052-D8B8A1ED-F802-404C-AFC4-7CEA9651C2DDQ28368053-762F63A3-0DEB-4408-BBBD-400AB54B5427Q28368086-E13346A6-FDB4-45BD-ACB5-B3C9C743863AQ28378626-942DFC7D-3E6C-41BA-892E-63B23ECB0924Q28378745-1731AC3F-74B8-4CD5-AB1F-F1F915FAA491Q28378789-6DC5DD6A-BE67-4033-8E7F-58B8C063BDF5Q28378859-47AE7669-1666-41B3-8AD4-DF1F0E7B319FQ28469069-2B2A4BC5-43CA-4088-B6B6-572F88954499Q33757596-1A2671FB-2760-4436-B298-2263147E7C3AQ35122784-16D25FA3-10B2-46E9-A515-637A44A664E8Q35312562-7FC8B10E-C66C-45C4-A72C-B82CA0E23205Q35366050-CA77D61C-411D-4F27-9B1B-BBB4D6486593Q36278914-4F94527A-0F2B-4FD5-9D9C-4BF9B540AB49Q39556617-5E904FD0-026C-4BEE-AE50-5066A6E0C9B1
P2860
Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Functional analysis of HIV-1 r ...... tiple nonnucleoside inhibitors
@ast
Functional analysis of HIV-1 r ...... tiple nonnucleoside inhibitors
@en
Functional analysis of HIV-1 r ...... tiple nonnucleoside inhibitors
@nl
type
label
Functional analysis of HIV-1 r ...... tiple nonnucleoside inhibitors
@ast
Functional analysis of HIV-1 r ...... tiple nonnucleoside inhibitors
@en
Functional analysis of HIV-1 r ...... tiple nonnucleoside inhibitors
@nl
prefLabel
Functional analysis of HIV-1 r ...... tiple nonnucleoside inhibitors
@ast
Functional analysis of HIV-1 r ...... tiple nonnucleoside inhibitors
@en
Functional analysis of HIV-1 r ...... tiple nonnucleoside inhibitors
@nl
P2093
P1476
Functional analysis of HIV-1 r ...... tiple nonnucleoside inhibitors
@en
P2093
A J Schlabach
D J Graham
D W Lineberger
J A Wolfgang
J H Condra
V V Sardana
P304
P407
P577
1992-09-05T00:00:00Z